Supportive Symptom Management and Monitoring in Comfort-Focused Care

1. Pharmacologic Symptom Management

The primary goal of pharmacotherapy in comfort care is to optimize drug therapy to relieve dyspnea, anxiety, agitation, and pain while minimizing adverse effects like excessive sedation and hemodynamic compromise.

Pharmacologic Agents for Symptom Management in Comfort Care
Agent Class	Typical Dosing & Titration	Key Monitoring Parameters	Clinical Considerations & Pitfalls
Opioids (Morphine, Hydromorphone)	Dyspnea: Morphine 2.5-5 mg PO or 2 mg IV q4h. Titrate by 25-50% daily based on dyspnea score. Use hydromorphone in renal failure.	Respiratory rate, sedation (RASS), blood pressure, patient-reported dyspnea (NRS 0-10).	Risk of sedation, hypotension, and constipation. Schedule doses to maintain steady state.
Benzodiazepines (Lorazepam, Midazolam)	Anxiety: Lorazepam 0.5-1 mg PO/SL q4-6h PRN. Agitation: Midazolam 1-2 mg IV q2h PRN.	Richmond Agitation-Sedation Scale (RASS) q4h, signs of delirium.	Can worsen ICU delirium. Reserve for severe anxiety not responsive to other measures.
Adjuvant Analgesics (Ketamine, Gabapentinoids)	Ketamine: 0.1-0.3 mg/kg/h infusion. Gabapentin: 100-300 mg PO at bedtime.	Psychotomimetic effects (hallucinations), sedation, pain scores.	Ketamine is opioid-sparing but requires careful titration. Gabapentinoids need dose adjustment in renal dysfunction.
Bronchodilators (Albuterol)	Nebulized 2.5 mg q4-6h for bronchospasm.	Wheezing, patient-reported breathing effort, heart rate.	Primarily for patients with a reversible bronchospastic component to their dyspnea.

Opioids for Dyspnea

Low-dose opioids relieve the sensation of breathlessness (dyspnea) without causing clinically significant hypoventilation when initiated at a low dose and titrated carefully against symptom scores. Hydromorphone is preferred in renal impairment due to its lack of active metabolites.

2. Non-Pharmacologic Interventions

First-line comfort measures often involve simple, low-risk strategies that can be highly effective and should be implemented for all patients receiving comfort-focused care.

For Dyspnea Relief: A hand-held fan directed at the face can stimulate the trigeminal nerve, reducing the sensation of breathlessness. Positioning the patient to sit upright or lean forward with arm support can also ease the work of breathing.
For Relaxation: Guided imagery, deep-breathing exercises, music therapy, and aromatherapy can significantly reduce anxiety and promote a sense of calm.

Fan Therapy vs. Oxygen

In patients who are not hypoxemic, therapy with a simple handheld fan directed at the cheeks and nose may provide greater subjective relief from dyspnea than supplemental oxygen. This is a safe, inexpensive, and empowering intervention for patients and families.

3. Prevention of Iatrogenic Complications

Proactive care is essential to prevent complications that can cause further discomfort, such as pressure injuries and symptoms of dehydration.

A. Pressure Injury Prevention

Immobile patients are at high risk for skin breakdown. Key preventive measures include:

Repositioning the patient at least every 2 hours.
Using pressure-reducing surfaces like high-density foam mattresses or alternating-pressure air beds.
Conducting daily skin inspections, with special attention to bony prominences.
Applying cushions or pillows to offload pressure points.

B. Dehydration Management

While aggressive IV hydration is typically avoided, managing thirst and dry mouth is a key comfort goal.

Oral Care: Frequent mouth care with swabs, ice chips, and lip balm is crucial for relieving dry mucosa. Encourage small, frequent sips of preferred liquids if the patient is able to swallow safely.
Subcutaneous Hydration (Hypodermoclysis): For persistent thirst unresponsive to oral care, low-volume subcutaneous hydration (500–1000 mL over 24 hours) can provide relief without the risks of fluid overload associated with IV fluids.

The Role of Hydration in End-of-Life Care

The decision to provide hydration is complex. Some clinicians and ethicists view mild dehydration as a natural part of the dying process that may reduce uncomfortable symptoms like pulmonary congestion and edema. Others advocate for low-volume hydration to specifically alleviate the symptom of thirst. The most appropriate approach is to align the strategy with the patient’s stated goals and comfort level, involving the patient and family in the decision-making process.

4. Monitoring Efficacy and Safety

Structured, routine assessments are critical to guide timely dose adjustments and detect adverse effects before they become severe. This ensures that interventions are effective and safe.

Figure 1: Symptom Monitoring Framework. Validated scales should be used to assess key symptoms at regular intervals (e.g., every 4 hours) and after any intervention to guide therapy.

Assessing the Non-Communicative Patient

For patients who cannot self-report their symptoms due to sedation or delirium, objective observational tools are essential. The Respiratory Distress Observation Scale (RDOS) is a validated tool that uses physical signs (e.g., heart rate, respiratory rate, accessory muscle use) to quantify dyspnea, allowing for consistent monitoring and titration of therapy.

5. Psychosocial and Spiritual Support Integration

Holistic comfort care extends beyond physical symptoms to address the emotional, existential, and spiritual distress that patients and their families often experience. An interdisciplinary approach is paramount.

Chaplaincy and Spiritual Care: Specialists can conduct spiritual assessments to understand a patient’s beliefs and values, offering support through prayer, rituals, readings, or simply a compassionate presence.
Social Work: Social workers are vital for facilitating family meetings, preparing loved ones for the dying process, and connecting them with resources. They can also coach families on how to participate in care through non-drug comfort techniques.
Complementary Therapies: Services like music therapy, massage, and pet therapy can enhance relaxation, reduce anxiety, and provide moments of joy and connection.

6. Implementation and Quality Metrics

Delivering consistent, high-quality comfort care requires standardized protocols, clear communication, and a commitment to continuous improvement.

Nurse-Led Symptom Rounds: Proactive, structured rounds to review symptom assessment scores ensure that symptoms are identified early and interventions are timely.
Audit and Quality Metrics: Institutions should track key metrics to measure the quality of care, such as the frequency of symptom assessments, time to first intervention for a reported symptom, documentation completeness, and rates of iatrogenic complications like pressure injuries.
Multidisciplinary Debriefs: Regular meetings involving pharmacy, nursing, spiritual care, and medical teams help refine protocols, address challenges, and ensure care remains aligned with patient and family goals.

References

Hui D, Yennu S, Bruera E, et al. Management of dyspnea in advanced cancer: ASCO guideline. J Clin Oncol. 2021;39(12):1389-1411.
Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disturbance in adult ICU patients. Crit Care Med. 2018;46(9):e825-e873.
Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for management of pain, agitation, and delirium in adult ICU patients. Crit Care Med. 2013;41(1):263-306.
Ferrell BR, Twaddle ML, Melnick A, et al. National Consensus Project Clinical Practice Guidelines for Quality Palliative Care, 4th ed. J Palliat Med. 2018;21(12):1684-1689.

Learning Objective